Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2007
10/23/2007CA2467871C Method for assay of antibodies and antibody assay device
10/23/2007CA2341946C Polypetides and compositions prepared from the amplification of the hiv-2 and siv-type retrovirus genome,
10/23/2007CA2298884C Direct quantitation of low copy number rna
10/23/2007CA2276053C Methods of conferring ppo-inhibiting herbicide resistance to plants by gene manipulation
10/23/2007CA2271697C Tissue type plasminogen activator (t-pa) variants: compositions and methods of use
10/23/2007CA2234416C Immunochemical determination of multivalent analytes
10/23/2007CA2175184C Cell separation device
10/23/2007CA2172840C Measuring method using whole blood sample
10/23/2007CA2142981C Vaccines against group c neisseria meningitidis
10/23/2007CA2111325C Detection of mammalian immunodeficiency viruses
10/18/2007WO2007118238A2 Constitutively resistant cancer stem cells in diagnosis
10/18/2007WO2007118218A2 Detection of silica species in hot phosphoric acid
10/18/2007WO2007118214A2 Antibody compositions and methods for treatment of neoplastic disease
10/18/2007WO2007118212A1 Method of predicting a trait of interest
10/18/2007WO2007118120A1 Method for multiplex bead-based assays using chemiluminescence and fluorescence
10/18/2007WO2007118095A2 Binding of complement factor h to c-reactive protein
10/18/2007WO2007118077A2 Mycobacterial catalase-peroxidase in the diagnosis and treatment of sarcoidosis
10/18/2007WO2007118046A2 Diagnostic meter
10/18/2007WO2007117763A2 Methods and compositions for targeting relt
10/18/2007WO2007117657A2 Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
10/18/2007WO2007117599A2 A method for measuring the content of a botulinum toxin in a formulation
10/18/2007WO2007117569A2 Methods of determining skeletal maturity
10/18/2007WO2007117564A2 Clay-binding peptides and methods of use
10/18/2007WO2007117553A2 Method of controlling insect pests in cotton
10/18/2007WO2007117507A1 A method for the assay of rock kinase activity in cells
10/18/2007WO2007117444A2 Protein detection by aptamers
10/18/2007WO2007117439A2 Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
10/18/2007WO2007117432A2 Methods and compositions for modulating angiogenesis and tumor growth
10/18/2007WO2007117405A1 Test strip calibration system for a glucose meter, and method
10/18/2007WO2007117346A2 Programming microfluidic devices with molecular information
10/18/2007WO2007117334A2 Document analysis system for integration of paper records into a searchable electronic database
10/18/2007WO2007117330A2 Latent protein c assays and their uses for diagnosis and/or prognosis in systemic inflammatory response syndromes
10/18/2007WO2007117290A2 Ceramic h2s sensor
10/18/2007WO2007117215A1 Binder for c-reactive protein
10/18/2007WO2007117161A1 Substituted ring fused azines and their use in cancer therapy
10/18/2007WO2007117155A1 Solid phase immuno-assay
10/18/2007WO2007117047A1 Apparatus and method for sizing testing
10/18/2007WO2007116975A1 METHOD FOR NON-INVASIVE EXAMINATION OF NON-ALCOHOLIC STEATOHEPATITIS BY QUANTIFICATION OF CYTOCHROME-c, AND TEST KIT
10/18/2007WO2007116945A1 Marker for predicting graft-versus-host disease and utilization of the same
10/18/2007WO2007116870A1 Method of preparing mature hepatocyte-like cell
10/18/2007WO2007116836A1 Detection method and separation method for foregut cell
10/18/2007WO2007116811A1 Method for determination of substance
10/18/2007WO2007116800A1 Type i interferon-unresponsive non-human model animal
10/18/2007WO2007116779A1 Novel platelet activation marker and method for determination thereof
10/18/2007WO2007116710A1 Glucose dehydrogenase
10/18/2007WO2007116675A1 Body fluid components measuring device
10/18/2007WO2007116597A1 Tumor marker, diagnostic kit for tumor, method for determination of tumor marker, and diagnostic method for tumor
10/18/2007WO2007116336A2 Method and apparatus for monitoring alteration of flow characteristics in a liquid sample
10/18/2007WO2007116199A1 Methods and reagents for diagnosing heart failure
10/18/2007WO2007116069A1 Method for suppressing a fret signal, fret signal suppressor agents and use in a method for multiplexing biological events
10/18/2007WO2007115807A1 Apparatus for performing dissolved gas analysis
10/18/2007WO2007115694A2 Miniaturised biosensor with optimized amperometric detection
10/18/2007WO2007115541A2 Method for producing surface structures and element having a surface structure for use in biosensors or for the production of cell guiding structures
10/18/2007WO2007115491A1 Rapid genotyping analysis and the device thereof
10/18/2007WO2007115444A1 Seperation or analysis composition comprising active nanostructure and seperation or analysis method
10/18/2007WO2007115416A1 Method and device for the analysis of moved, solid, elongate test material
10/18/2007WO2007115398A1 Treatment of elevated c-reactive protein levels
10/18/2007WO2007115376A1 Anti-angiogenic agents and methods of their use
10/18/2007WO2007101662A3 Safety approach for diagnostic systems
10/18/2007WO2007093049A9 Kinase and phosphatase assays conducted by elemental analysis
10/18/2007WO2007092627A9 Detection of cancer by elevated levels of bcl-2
10/18/2007WO2007086986A3 Novel application of biosensors for diagnosis and treatment of disease
10/18/2007WO2007083170B1 Molecular identification through membrane-engineered cells
10/18/2007WO2007079301A3 Method of diagnosing a body weight condition or predisposition in an animal
10/18/2007WO2007077543A3 Sigma-2 receptor, method of screening of specific ligands and use of the same in diagnostic or therapeutic methods
10/18/2007WO2007077464A3 Chicken virus vaccine and diagnostic
10/18/2007WO2007076439A3 Methods and marker combinations for screening for predisposition to lung cancer
10/18/2007WO2007076339A3 Isotopically labelled crosslinking agents for the analysis of protein interactions
10/18/2007WO2007075179A3 Bacteriophage-quantum dot (phage-qd) nanocomplex to detect biological targets in clinical and environmental isolates
10/18/2007WO2007072373A3 A sensor for biomolecules and a method of analysis using said sensor
10/18/2007WO2007066231A3 Rapid elisa
10/18/2007WO2007044935A3 Methods for the development of a biomolecule assay
10/18/2007WO2007043012A3 Vial for test strips
10/18/2007WO2007035494A3 Inducing expression of puma to reduce joint inflammation in the treatment of arthritis
10/18/2007WO2007022530A3 Quantification of microsphere suspension hybridization and uses thereof
10/18/2007WO2007016257A3 Method for evaluating drug candidates
10/18/2007WO2007014132A3 Hmgcr isoforms in prediction of efficacy and identification of cholesterol-modulating compounds
10/18/2007WO2006102401A3 Normalization of gene expression data
10/18/2007WO2006088951A9 Cd38 modulated chemotaxis
10/18/2007WO2002088707A3 Biopolymer marker having a molecular weight of 1998 daltons
10/18/2007WO2002061054A3 Method for increasing the virus propagation and the virus yield in cell cultures by blocking the activation of rnasel
10/18/2007WO2002010354A3 Secretase/sheddase with asp-ase activity on the beta-site app-cleaving enzyme (bace, asp2, memepsin 2)
10/18/2007WO2002010198A3 Polynucleotides and polypeptides
10/18/2007US20070244412 Medical apparatus for use by a patient for medical self treatment of diabetes
10/18/2007US20070244313 Method for detecting base mutation
10/18/2007US20070244304 Methods of Identifying Neoplasm-Specific Antibodies and Uses Thereof
10/18/2007US20070244297 Human calcium channel compositions and methods
10/18/2007US20070244174 Chemical Inhibitors of Soluble Adenylyl Cyclase (Sac)
10/18/2007US20070244063 Inducing angiogenesis comprising contacting endothelial cells expressing Bv8 receptor with a polypeptide comprising the amino acid sequence of SEQ ID NO:2; using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival; screening for Bv8 modulators
10/18/2007US20070244061 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondisn) and/or Wnt
10/18/2007US20070244035 Novel co-modulators of nuclear receptors and methods of detecting and treating steroid hormone-dependent diseases using same
10/18/2007US20070244033 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a c-myc protein
10/18/2007US20070244030 Method for Assessing Cancerous State
10/18/2007US20070243637 Process and device for determining the concentrations of ligands
10/18/2007US20070243636 Method and apparatus for mass spectrometric immunoassay analysis of specific biological fluid proteins
10/18/2007US20070243635 Method and apparatus for mass spectrometric immunoassay analysis of specific biological fluid proteins
10/18/2007US20070243634 Droplet-based surface modification and washing
10/18/2007US20070243633 Biosensor
10/18/2007US20070243632 Methods for measuring platelet reactivity of patients that have received drug eluting stents
10/18/2007US20070243631 Determination of concentration of fk778 by competitive immunoassay